Literature DB >> 28870466

IL-12 and IL-7 synergize to control mucosal-associated invariant T-cell cytotoxic responses to bacterial infection.

Joshua C Wallington1, Anthony P Williams2, Karl J Staples3, Tom M A Wilkinson4.   

Abstract

BACKGROUND: Bacterial respiratory tract infections and exacerbations of chronic lung diseases are commonly caused by nontypeable Haemophilus influenzae (NTHi). Cell-mediated cytotoxicity might be key to controlling infection, but the responses of NTHi-specific T-cell populations are not well understood. Mucosal-associated invariant T (MAIT) cells are a recently discovered, innate-like subset of T cells with cytotoxic function, the role of which in lung immunity is unclear.
OBJECTIVE: The aim of this study was to determine the mechanisms behind conventional T-cell and MAIT cell cytotoxic responses to NTHi.
METHODS: Human ex vivo lung explants were infected with a clinical strain of NTHi. Monocyte-derived macrophages were also infected with NTHi in vitro and cocultured with autologous T cells. Cytotoxic responses of T-cell subsets were measured by using flow cytometry.
RESULTS: We found significant upregulation of the cytotoxic markers CD107a and granzyme B in lung CD4+, CD8+, and MAIT cell populations. We show that MAIT cell cytotoxic responses were upregulated by a combination of both time-dependent antigen presentation and a novel mechanism through which IL-12 and IL-7 synergistically control granzyme B through upregulation of the IL-12 receptor.
CONCLUSIONS: Overall, our data provide evidence for a cytotoxic role of MAIT cells in the lung and highlight important differences in the control of adaptive and innate-like T-cell responses. Understanding these mechanisms might lead to new therapeutic opportunities to modulate the antibacterial response and improve clinical outcome.
Copyright © 2017 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  T cells; bacterial infection; cytotoxicity; mucosal-associated invariant T cells

Mesh:

Substances:

Year:  2017        PMID: 28870466     DOI: 10.1016/j.jaci.2017.08.009

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  21 in total

1.  Structural basis for IL-12 and IL-23 receptor sharing reveals a gateway for shaping actions on T versus NK cells.

Authors:  Caleb R Glassman; Yamuna Kalyani Mathiharan; Kevin M Jude; Leon Su; Ouliana Panova; Patrick J Lupardus; Jamie B Spangler; Lauren K Ely; Christoph Thomas; Georgios Skiniotis; K Christopher Garcia
Journal:  Cell       Date:  2021-02-18       Impact factor: 41.582

2.  Dysregulation of COVID-19 related gene expression in the COPD lung.

Authors:  Lisa Öberg; Bastian Angermann; Alastair Watson; C Mirella Spalluto; Michael Hühn; Hannah Burke; Doriana Cellura; Anna Freeman; Daniel Muthas; Damla Etal; Graham Belfield; Fredrik Karlsson; Karl Nordström; Kris Ostridge; Karl J Staples; Tom Wilkinson
Journal:  Respir Res       Date:  2021-05-29

Review 3.  Factors Influencing Functional Heterogeneity in Human Mucosa-Associated Invariant T Cells.

Authors:  Joana Dias; Caroline Boulouis; Michał J Sobkowiak; Kerri G Lal; Johanna Emgård; Marcus Buggert; Tiphaine Parrot; Jean-Baptiste Gorin; Edwin Leeansyah; Johan K Sandberg
Journal:  Front Immunol       Date:  2018-07-10       Impact factor: 7.561

4.  Mucosal-associated invariant T cells in hepatitis B virus-related liver failure.

Authors:  Hong Xue; Han Li; Lin-Ling Ju; Xu-Dong Han; Tiao-Chun Cheng; Xi Luo; Lin Chen; Jian-Guo Shao; Yong-Jun She; Zhao-Lian Bian
Journal:  World J Gastroenterol       Date:  2020-08-21       Impact factor: 5.742

5.  MAIT cells contribute to protection against lethal influenza infection in vivo.

Authors:  Bonnie van Wilgenburg; Liyen Loh; Zhenjun Chen; Troi J Pediongco; Huimeng Wang; Mai Shi; Zhe Zhao; Marios Koutsakos; Simone Nüssing; Sneha Sant; Zhongfang Wang; Criselle D'Souza; Xiaoxiao Jia; Catarina F Almeida; Lyudmila Kostenko; Sidonia B G Eckle; Bronwyn S Meehan; Axel Kallies; Dale I Godfrey; Patrick C Reading; Alexandra J Corbett; James McCluskey; Paul Klenerman; Katherine Kedzierska; Timothy S C Hinks
Journal:  Nat Commun       Date:  2018-11-09       Impact factor: 14.919

Review 6.  Innate Immune Cell Suppression and the Link With Secondary Lung Bacterial Pneumonia.

Authors:  David J Morgan; Joshua Casulli; Christine Chew; Emma Connolly; Sylvia Lui; Oliver J Brand; Rizwana Rahman; Christopher Jagger; Tracy Hussell
Journal:  Front Immunol       Date:  2018-12-14       Impact factor: 7.561

Review 7.  T cells in severe childhood asthma.

Authors:  Alberta G A Paul; Lyndsey M Muehling; Jacob D Eccles; Judith A Woodfolk
Journal:  Clin Exp Allergy       Date:  2019-04-04       Impact factor: 5.018

Review 8.  Insights Into Mucosal-Associated Invariant T Cell Biology From Studies of Invariant Natural Killer T Cells.

Authors:  Lucy C Garner; Paul Klenerman; Nicholas M Provine
Journal:  Front Immunol       Date:  2018-06-28       Impact factor: 7.561

Review 9.  Antigen Recognition by MR1-Reactive T Cells; MAIT Cells, Metabolites, and Remaining Mysteries.

Authors:  Alexandra J Corbett; Wael Awad; Huimeng Wang; Zhenjun Chen
Journal:  Front Immunol       Date:  2020-08-27       Impact factor: 7.561

Review 10.  Invariant Natural Killer T and Mucosal-Associated Invariant T Cells in Asthmatic Patients.

Authors:  Guillaume Lezmi; Maria Leite-de-Moraes
Journal:  Front Immunol       Date:  2018-07-30       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.